Chemoinformaics analysis of 10,20-Dihydroxyeicosanoic acid
| Molecular Weight | 344.536 | nRot | 19 |
| Heavy Atom Molecular Weight | 304.216 | nRig | 1 |
| Exact Molecular Weight | 344.293 | nRing | 0 |
| Solubility: LogS | -3.824 | nHRing | 0 |
| Solubility: LogP | 4.993 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 64 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 63.2797 |
| nHD | 3 | BPOL | 40.9963 |
| QED | 0.286 |
| Synth | 2.553 |
| Natural Product Likeliness | 0.798 |
| NR-PPAR-gamma | 0.982 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.01 |
| HIA | 0.038 |
| CACO-2 | -5.318 |
| MDCK | 0.0000392 |
| BBB | 0.105 |
| PPB | 0.964311 |
| VDSS | 0.619 |
| FU | 0.0149341 |
| CYP1A2-inh | 0.065 |
| CYP1A2-sub | 0.168 |
| CYP2c19-inh | 0.037 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.114 |
| CYP2c9-sub | 0.983 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.045 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.011 |
| CL | 5.851 |
| T12 | 0.743 |
| hERG | 0.057 |
| Ames | 0.004 |
| ROA | 0.003 |
| SkinSen | 0.938 |
| Carcinogencity | 0.076 |
| EI | 0.953 |
| Respiratory | 0.175 |
| NR-Aromatase | 0.319 |
| Antiviral | Yes |
| Prediction | 0.636871 |